The effects of gallium nitrate on bone resorption

Seminars in Oncology

Volumn 30, Issue 2 SUPPL. 5, 2003, Pages 5-12

  Bockman, Richard ^a  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; ETIDRONIC ACID; GALLIUM NITRATE; HYDROXYAPATITE; PAMIDRONIC ACID; PHOSPHATE; PROTON PUMP;

APOPTOSIS; BONE METASTASIS; BONE MINERAL; BONE STRENGTH; BONE TISSUE; CLINICAL TRIAL; CRYSTALLIZATION; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; DRUG FORMULATION; DRUG MECHANISM; HUMAN; HYPERCALCEMIA; LOW DRUG DOSE; MULTIPLE MYELOMA; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; PAGET BONE DISEASE; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTINEOPLASTIC AGENTS; BONE AND BONES; BONE DENSITY; BONE RESORPTION; GALLIUM; HUMANS; OSTEITIS DEFORMANS; OSTEOCLASTS;

EID: 0038486159     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0093-7754(03)00170-2     Document Type: Review

References (34)

1. Bertheault-Cvitkovic F, Armand J-P, Tubiana-Hulin M, et al: Randomized, double-blind comparison of pamidronate vs. gallium nitrate for acute control of cancer-related hypercalcemia. Presented at the 9th EORTC/NCI Symposium, Amsterdam, March 1996
2. Warrell RP Jr, Murphy WK, Schulman P, et al: A randomized double-blind study of gallium nitrate compared with etidronate for acute control of cancer-related hypercalcemia. J Clin Oncol 9:1467-1475, 1991
3. Warrell RP Jr, Israel R, Frisone M, et al: Gallium nitrate for acute treatment of cancer-related hypercalcemia. A randomized, double-blind comparison to calcitonin. Ann Intern Med 108:669-674, 1988
4. Warrell RP Jr, Alcock NW, Bockman RS: Gallium nitrate inhibits accelerated bone turnover in patients with bone metastases. J Clin Oncol 5:292-298, 1987
5. Warrell RP Jr, Lovett D, Dilmanian FA, et al: Low-dose gallium nitrate for prevention of osteolysis in myeloma: Results of a pilot randomized study, J Clin Oncol 11: 2443-2450, 1993
6. Bockman RS, Wilhelm F, Siris E, et al: A multicenter trial of low dose gallium nitrate in patients with advanced Paget's disease of bone. J Clin Endocrinol Metab 80:595-602, 1995
7. Warrell RP Jr, Bosco B, Weinerman S, et al: Gallium nitrate for advanced Paget disease of bone: effectiveness and dose-response analysis. Ann Intern Med 113:847-851, 1990
8. Blumenthal NC, Cosma V: The effect of aluminum and gallium ions on the mineralization process. Bull Hosp Jt Dis Orthop Inst 49:192-204, 1989
9. Donnelly R, Boskey A: The effect of gallium on seeded hydroxyapatite growth. Calcif Tissue Int 44:138-142, 1989
10. Bockman RS: Studies on the mechanism of action of gallium nitrate. Semin Oncol 18:21-25, 1991 (suppl 5)
11. 75) in skeletal tissues. J Pharmacol Exp Ther 96: 224-227, 1949
12. Nelson B, Hayes RL, Edwards CL, et al: Distribution of gallium in human tissues after intravenous administration. J Nucl Med 13:92-100, 1972
13. Hoffer P: Gallium and infection. J Nucl Med 21:484-488, 1980
14. McCall TW, Sheppard H, Haddaway M, et al: Gallium 67 scanning in rheumatoid arthritis. Br J Radiol 56: 241-243, 1983
15. Tsan MF: Mechanism of gallium-67 accumulation in inflammatory lesions. J Nucl Med 26:88-92, 1985
16. Bockman RS, Boskey AL, Blumenthal NC, et al: Gallium increases bone calcium and crystallite perfection of hydroxyapatite. Calcif Tissue Int 39:376-381, 1986
17. Repo MA, Bockman RS, Betts F, et al: Effect of gallium on bone mineral properties. Calcif Tissue Int 43:300-306, 1988
18. 67Gallium binding to human serum proteins and tumor components. Cancer Res 34:1931-1937, 1974
19. Vallabhajosula SR, Harwig JF, Siemsen JK, et al: Radiogallium localization in tumors: Blood binding and transport and the role of transferrin. J Nucl Med 21:650-656, 1980
20. Lentle BC, Penney H, Ensslen RA: Generalized increase in uptake of gallium-67 in bone. Semin Nucl Med 14:143-145, 1984
21. Sohn M-H, Jones BJ, Whiting JH Jr, et al: Distribution of gallium-67 in normal and hypotransferrinemic tumor-bearing mice. J Nucl Med 34:2135-2143, 1993
22. Bockman RS, Repo MA, Warrell RP Jr, et al: Distribution of trace levels of therapeutic gallium in bone as mapped by synchrotron x-ray microscopy. Proc Natl Acad Sci U S A 87:4149-4153, 1990
23. Dudley HC, Marrer HH: Studies of the metabolism of gallium III deposition in and clearance from bone. J Pharmacol Exp Ther 106:129-134, 1952
24. 72 in rats. Radiology 61:555-570, 1953
25. Bernstein LR: Mechanisms of therapeutic activity for gallium. Pharmacol Rev 50:665-682, 1998
26. Donnelly R, Bockman R, DiCarlo E, et al: The effect of gallium nitrate on healing of vitamin D- and phosphate-deficient rickets in the immature rat. Calcif Tissue Int 53:400-410, 1993
27. Donnelly R, Bockman RS, Doty SB, et al: Bone particles from gallium-treated rats are resistant to resorption in vivo. Bone Miner 12:167-179, 1991
28. Lane JM, Betts F, Posner AS, et al: Mineral parameters in early fracture repair. J Bone Joint Surg 66:1289-1293, 1984
29. Posner AS, Betts F, Blumenthal NC: Bone mineral composition and structure, in Kunin A, Simmons D (eds): Skeletal Research. New York, NY, Academic Press, 1979, pp 67-192
30. Hall TJ, Chambers TJ: Gallium inhibits bone resorption by a direct effect on osteoclasts. Bone Miner 8:211-216, 1990
31. 3+ contrasts with bisphosphonate metabolic suppression: Competitive inhibition of H+ ATPase by bonebound gallium. J Bone Miner Res 6: S127, 1991 (abstr)
32. Matkovic V, Apseloff G, Shepard DR, et al: Use of gallium to treat Paget's disease of bone: A pilot study. Lancet 335:72-75, 1990
33. Luckman SP, Hughes DE, Coxon FP, et al: Nitrogencontaining bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras. J Bone Miner Res 13:581-589, 1998
34. 2MDP) on the calcification and resorption of cartilage and bone in the tibial epiphysis and metaphysis of rats. Calcif Tissue Res 11:196-214, 1973